Investigating the role of the Mob4 gene in Alzheimer's disease

Mob4 activity and dysfunction in Alzheimer's Disease

NIH-funded research University of Minnesota · NIH-10879035

This study is looking at how a gene called Mob4, which is less active in people with Alzheimer's, affects brain cell functions, especially how they transport important materials and help with memory, to find new ways to understand and possibly treat the disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota NIH-funded
Lab location1 site (Minneapolis, United States)
Project IDNIH-10879035 on NIH RePORTER

What this research studies

This research focuses on understanding how the Mob4 gene, which is significantly downregulated in Alzheimer's disease, affects neuronal functions. The study aims to explore the molecular mechanisms of Mob4 in neurons, particularly its role in regulating axonal transport and memory formation, which are critical processes impacted by Alzheimer's. By examining the interactions of Mob4 with other proteins in the STRIPAK complex, researchers hope to uncover new insights into the disease's progression and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or preventing Alzheimer's disease by targeting the molecular pathways involving Mob4.

How similar studies have performed: While the specific role of Mob4 in Alzheimer's is being investigated for the first time, similar studies on other genes have shown promise in understanding neurodegenerative diseases.

Where this research is happening

Minneapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.